US approves 'Truvada', the first pill to help prevent HIV
The agency approved Gilead Sciences' pill Truvada as a preventive measure for people who are at high risk of acquiring HIV, such as those who have sex with HIV-infected partners.
Gilead Sciences Inc. has marketed Truvada since 2004 as a treatment for people who are infected with the virus.
But company studies have shown the drug can prevent people from contracting HIV when used as a precautionary measure. A three-year study found that daily doses cut the risk of infection in healthy gay and bisexual men by 42 per cent, when accompanied by condoms and counseling.
Amidst tight security, counting began for the 200 member Assembly elections for the Rajasthan Assembly. Counting will be held for 199 seats as one seat was countermanded following the death of a candidate.
Date 9 hrs ago, Duration 1:07, Views 0